Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders

View source ↗

Summary

A completed clinical trial evaluating nasal biomarkers for objective assessment of disease severity in chronic respiratory diseases, including COPD and asthma, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Diag-Nose Medical Pty Ltd | Conditions: Chronic Obstructive Pulmonary Disease (COPD), Asthma Patients | Status: COMPLETED